Sanofi is a French maker of medicines and vaccines headquartered in Paris. Its eczema and asthma drug Dupixent is about 36% of its sales and vaccines about 18%, and the US is half its market; it sold control of its consumer health business, Opella, in 2025.
Sanofi was incorporated in 1994. It had 74,846 employees and €43.6 billion net sales in 2025.
Founded 1994Head office Paris, FranceStaff ~74,846 (end 2025)Revenue ~€43.6B net sales (FY2025)Website ↗
Sanofi's own emissions are 49% below 2019, but its total of 4.45 MtCO2e was flat in 2025 because its supply-chain emissions rose slightly. Its targets are SBTi-validated, though its supply-chain target is in line only with 2°C. 86% of its electricity is renewable, much of it through unbundled certificates, but renewables are only 43% of all its energy. InfluenceMap finds it belongs to trade groups that oppose climate policy, including the US Chamber of Commerce.
Sanofi scores 48/100 (Making progress) on SINK's independent climate assessment, scored from public data only. Scores are free. Companies can never pay for anything about their own score. Last verified October 2026.
That places Sanofi joint 210th of 934 companies scored, and joint 8th of 22 in Healthcare / Pharmaceuticals.
Strongest on Carbon Footprint: Operations and Carbon Footprint: Supply Chain (9/10, 8/10). Weakest on Emissions Trajectory and Nature & Biodiversity Impact (4/10, 5/10).
For each question that lost points, the evidence our public rubric looks for that we didn't find.
A score changes when the evidence does. We use new published evidence at the next rescore. Anyone can send us new evidence, free. How to send it.
Same ten questions for every company. No private weighting.
SINK = (0.3 × Base + 0.7 × Performance) × ScaleSanofi's score has moved from 50 to 48 across 2 recorded reviews, down 2 points.
Re-scored under the current methodology (v2.5); owner ruling 2026-10-29
Initial score at platform launch
8 sources used in this assessment. All publicly available. Each row shows which of the ten questions it informed.
50% of them were published by Sanofi itself; the rest come from independent sources.
“Total Scope 1 and Scope 2 CO e emissions fell by 49% between 2019 and 2025”
“49% decrease in scopes 1 and 2 GHG emissions (vs the 2019 baseline).”
“Following TNFD recommendations, Sanofi launched a LEAP (Locate, Evaluate, Assess, Prepare) assessment in 2025”
“29% reduction of our global water withdrawals (vs. 2019 baseline)”
“quantification and compliance levels remain unclear”
“This company received a CDP Water Security score of B.”
“The company retains members to several associations whose advocacy is misaligned, including the German Chemical Industry Association (VCI)”
“The installation will generate approximately 3.2GWh of renewable electricity annually”
If you believe a source has been misread or a newer version exists, submit a challenge.
Use this score in tenders
Send the link, or the one-page score sheet. It links back to this page and every source. Free.
Open the score sheet →Send new evidence, free
Scored low because little is published? Publish what you do and send us the link, free. If it holds up, your score changes, and the change is logged on your page.
How to send evidence →Put your score on your website, free
It shows the current score and links to this page, so it changes when the score does.
Track this score
Bidding for a public contract? Check if you need a Carbon Reduction Plan, free →
Free, independent, every source shown. Send it to any buyer who asks about your sustainability.
Where Sanofi sits among healthcare / pharmaceuticals peers.
Among the 22 major healthcare / pharmaceuticals brands we've scored, Sanofi is tied =8th of 22, with 1 other.
The 3 companies in the sector scoring nearest above Sanofi.
Haleon reports comprehensively on Scope 1+2 emissions and has achieved 100% renewable electricity, with verified 55% net reduction versus 2020.
See the breakdown →Philips's own emissions are 85% below 2015, mainly because its electricity is now 100% renewable, half of it through power purchase agreements.
See the breakdown →Roche has achieved strong operational decarbonisation (46% S1&2 reduction since 2022) and received SBTi validation for net-zero targets — a pharma first.
See the breakdown →One email, every Sunday. Score changes, new research, the stories behind the numbers. Free.
We'll send one email to confirm. No spam. Unsubscribe in one click.
Checking a company?
Search free →Asked to prove you're sustainable?
Get your business scored, free →Been scored?
Find your page and claim it, free →Scores are free. Companies can never pay for anything about their own score.